HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ming He Selected Research

22-O-angeloylcamelliagenin C- 3- O- (glucopyranosyl- 1- 2)(glucopyranosyl- 1- 2- O- arabinopyranosyl- 1- 3- )glucopyranosiduronic acid

7/2012Sasanquasaponin up-regulates anion exchanger 3 expression and elicits cardioprotection via NO/RAS/ERK1/2 pathway.
10/2011Anion exchanger 3 is required for sasanquasaponin to inhibit ischemia/reperfusion-induced elevation of intracellular Cl- concentration and to elicit cardioprotection.
12/2007Sasanquasaponin protects rat cardiomyocytes against oxidative stress induced by anoxia-reoxygenation injury.
11/2007Protective effects of sasanquasaponin on injury of endothelial cells induced by anoxia and reoxygenation in vitro.
8/2005Inhibitory effects of sasanquasaponin on over-expression of ICAM-1 and on enhancement of capillary permeability induced by burns in rats.
3/2004Effects of sasanquasaponin on ischemia and reperfusion injury in mouse hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ming He Research Topics

Disease

14Anoxia (Hypoxia)
08/2015 - 03/2004
9Neoplasms (Cancer)
06/2015 - 06/2003
8Ischemia
08/2015 - 03/2004
8Reperfusion Injury
03/2015 - 03/2004
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2015 - 06/2003
4Body Weight (Weight, Body)
04/2013 - 08/2005
4Infection
06/2011 - 07/2005
3Carcinoma (Carcinomatosis)
02/2016 - 06/2003
3Inflammation
07/2015 - 10/2010
3Myocardial Ischemia (Ischemic Heart Diseases)
03/2015 - 04/2006
3Type 2 Diabetes Mellitus (MODY)
02/2015 - 08/2012
3Thrombosis (Thrombus)
01/2012 - 03/2002
3Esophageal Neoplasms (Esophageal Cancer)
08/2007 - 07/2003
3Burns
04/2006 - 08/2005
2Hyperglycemia
09/2015 - 05/2015
2Atherosclerosis
06/2015 - 05/2013
2Insulin Resistance
05/2015 - 10/2010
2Iron Overload
11/2014 - 04/2013
2Necrosis
06/2014 - 11/2007
2Fibrosis (Cirrhosis)
04/2013 - 03/2005
2Adenoma (Adenomas)
02/2013 - 06/2003
2Obesity
10/2010 - 08/2008
2Lyme Disease (Disease, Lyme)
01/2010 - 09/2008
2Lung Neoplasms (Lung Cancer)
09/2006 - 07/2003
2Heart Neoplasms
06/2003 - 06/2003
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2016
1Postmenopausal Osteoporosis
06/2015
1Infarction
03/2015
1Atherosclerotic Plaque (Atheroma)
01/2015
1Bone Resorption
07/2014
1Endometriosis (Adenomyosis)
03/2014
1Ovarian Neoplasms (Ovarian Cancer)
03/2014
1Fatty Liver
11/2013
1Cardiovascular Diseases (Cardiovascular Disease)
10/2013
1Male Infertility (Male Sterility)
08/2013
1Rheumatoid Arthritis
06/2013
1Hepatocellular Carcinoma (Hepatoma)
06/2013
1Experimental Arthritis
06/2013

Drug/Important Bio-Agent (IBA)

8Reactive Oxygen Species (Oxygen Radicals)IBA
09/2015 - 12/2007
622-O-angeloylcamelliagenin C- 3- O- (glucopyranosyl- 1- 2)(glucopyranosyl- 1- 2- O- arabinopyranosyl- 1- 3- )glucopyranosiduronic acidIBA
07/2012 - 03/2004
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2015 - 06/2007
3DNA (Deoxyribonucleic Acid)IBA
02/2016 - 07/2003
3NF-kappa B (NF-kB)IBA
05/2015 - 11/2007
3Glucose (Dextrose)FDA LinkGeneric
05/2015 - 07/2008
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2015 - 08/2012
3Proteins (Proteins, Gene)IBA
10/2013 - 03/2011
3Messenger RNA (mRNA)IBA
05/2013 - 04/2006
3Interleukin-2 (IL2)IBA
03/2011 - 09/2006
3Lipoproteins (Lipoprotein)IBA
01/2010 - 09/2008
3CalciumIBA
05/2009 - 12/2007
3ferulic acid (sodium ferulate)IBA
01/2009 - 05/2004
2Phosphotransferases (Kinase)IBA
07/2015 - 05/2013
2Estrogens (Estrogen)FDA Link
06/2015 - 08/2012
2MicroRNAs (MicroRNA)IBA
06/2015 - 05/2011
2Apolipoproteins E (ApoE)IBA
01/2015 - 05/2013
2IronIBA
11/2014 - 04/2013
2NAD (NADH)IBA
11/2013 - 12/2003
2Adenosine Triphosphate (ATP)IBA
08/2013 - 06/2007
2Nitric Oxide Synthase (NO Synthase)IBA
06/2013 - 01/2009
2CytokinesIBA
05/2013 - 09/2006
2VanadiumIBA
03/2013 - 12/2012
2Streptozocin (Streptozotocin)FDA Link
03/2013 - 12/2012
2Protein Isoforms (Isoforms)IBA
08/2012 - 04/2006
214-3-3 Proteins (14-3-3 Protein)IBA
08/2012 - 07/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2011 - 09/2006
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2009 - 04/2006
21-oleoyl-2-stearoylphosphatidylcholineIBA
12/2008 - 09/2008
2AntigensIBA
08/2008 - 09/2006
2Liposomes (Liposome)IBA
12/2007 - 04/2007
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
12/2007 - 04/2007
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2007 - 08/2005
2Malondialdehyde (Propanedial)IBA
11/2007 - 06/2007
2Glyburide (Glibenclamide)FDA LinkGeneric
06/2007 - 04/2006
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
04/2006 - 05/2004
2CD40 Ligand (CD40L)IBA
10/2003 - 03/2002
2Cyclin D1IBA
06/2003 - 06/2003
1Ribosomal Proteins (Ribosomal Protein)IBA
02/2016
1isocitric acid (isocitrate)IBA
02/2016
1Ribonucleases (Ribonuclease)IBA
02/2016
1kaempferolIBA
08/2015
1rutecarpineIBA
06/2015
1ConnexinsIBA
06/2015
1PPAR gammaIBA
05/2015
1OsteopontinIBA
04/2015
1resveratrolIBA
03/2015
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2015
1tongxinluoIBA
01/2015
1TaurineFDA Link
11/2014
1daidzeinIBA
07/2014
1Phytoestrogens (Phytoestrogen)IBA
07/2014
1GenisteinIBA
07/2014
1Protein Kinase C-epsilonIBA
06/2014
1puerarinIBA
06/2014
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
03/2014
1ChromatinIBA
11/2013
1QuercetinIBA
10/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2013

Therapy/Procedure

2Esophagectomy
08/2015 - 08/2007
1Estrogen Replacement Therapy
06/2015
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2015